Thursday, September 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Domo Shares Gain Momentum on Strategic AI Partnerships and Analyst Confidence

Robert Sasse by Robert Sasse
September 13, 2025
in AI & Quantum Computing, Analysis, Tech & Software
0
Domo Stock
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

Domo Inc. (DOMO) demonstrated notable strength in Friday’s trading session, closing at $17.01 for a gain of 0.89%. The positive momentum is fueled by a combination of encouraging analyst sentiment and a major new strategic alliance with global electronics leader Panasonic.

Strategic Alliance Delivers Concrete Operational Benefits

A significant development emerged on September 10th with the formal announcement of a strategic partnership between Domo and Panasonic. The multinational corporation is leveraging Domo’s artificial intelligence platform to enhance its digital customer support services and accelerate product innovation. The collaboration is already yielding measurable results, notably saving an estimated 180 hours of manual labor each month. Furthermore, the use of automated FAQ solutions has increased thirtyfold compared to traditional telephone inquiries, providing clear evidence of the platform’s practical utility and return on investment.

Market Analysts Reinforce Bullish Stance

The investment case for Domo received a substantial boost this week as two separate firms issued positive commentary. Research analysts at JMP Securities reaffirmed their “Market Outperform” rating on the stock, maintaining a price target of $20. In a more assertive move, Cantor Fitzgerald upgraded its outlook, raising its price target from $17 to $20.

These optimistic positions are underpinned by several key factors. Analysts highlighted Domo’s successful collaborations with technology giants such as Amazon Web Services (AWS) and Google BigQuery. They also identified burgeoning demand for advanced AI solutions as a primary growth catalyst, a view supported by encouraging remarks from Domo’s Chief Financial Officer regarding robust new lead generation.

Should investors sell immediately? Or is it worth buying Domo?

A Path to Recovery After Initial Market Skepticism

The current upbeat mood marks a sharp reversal from the sentiment in late August. At that time, the share price fell approximately 13% following the Q2 earnings release, an event that occurred despite the company surpassing expectations and reporting its first-ever positive earnings per share. The decline was largely attributed to market apprehension over Domo’s strategic shift toward a consumption-based pricing model.

Recent developments, however, suggest investors are beginning to appreciate the long-term vision championed by CEO Josh James. The expansion of the existing AWS partnership to include support for generative AI initiatives further underscores the company’s strategic ambitions.

From a technical perspective, key moving averages are indicating the emergence of a bullish medium-term trend. Immediate resistance levels are identified at $17.52 and $18.81, while support is expected to hold at $13.37 and $12.09.

Looking ahead, management has provided Q3 revenue guidance in the range of $78.5 million to $79.5 million. For the full fiscal year, total revenue is projected to land between $316 million and $320 million, a forecast that aligns closely with current analyst consensus.

Ad

Domo Stock: Buy or Sell?! New Domo Analysis from September 18 delivers the answer:

The latest Domo figures speak for themselves: Urgent action needed for Domo investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 18.

Domo: Buy or sell? Read more here...

Tags: DOMO
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Conmed Stock
Analysis

Can a New Board Appointment Reverse CONMED’s Fortunes?

September 18, 2025
Xiaomi Stock
Asian Markets

Xiaomi’s Strategic Product Offensive Targets Apple’s Market Dominance

September 18, 2025
FoxClass A Stock
Analysis

Leadership Transition at Fox: Murdoch Consolidates Control Amid Strategic Shifts

September 18, 2025
Next Post
Redwood Stock

Redwood Trust Maintains Consistent Dividend Payouts Amid Market Volatility

Gossamer Bio Stock

Speculative Trading Surges Around Gossamer Bio's Pivotal Drug Data

CorMedix Stock

Strategic Moves and Insider Activity Shape CorMedix's Trajectory

Recommended

RLI stock news

Chicago Partners Investment Group LLC’s Surprising Reduction in Stake Raises Questions for Qurate Retail

2 years ago
BioXcel Stock

BioXcel Therapeutics Gains Key FDA Alignment for Supplemental Drug Application

4 weeks ago
NKT Holding Stock

NKT Holding Stock: Soars on Record Earnings and Upgraded Outlook

1 month ago
Technology Data analytics Stock Exchange

Notable Insider Trades in Amazon and Zoom Video

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Xiaomi’s Strategic Product Offensive Targets Apple’s Market Dominance

Leadership Transition at Fox: Murdoch Consolidates Control Amid Strategic Shifts

A Deep Dive into Design Therapeutics: Clinical Progress and Investor Confidence

Major Shareholder Exit Sends Redwire Shares Tumbling

US Regulatory Blow and Mixed Outlook Challenge Delta Air Lines

Polestar’s Financial Crossroads: Surging Sales Amid Deepening Losses

Trending

Conmed Stock
Analysis

Can a New Board Appointment Reverse CONMED’s Fortunes?

by Robert Sasse
September 18, 2025
0

The medical technology firm CONMED has appointed a new director to its board, bringing in seasoned industry...

Alx Oncology Holdings  Stock

Alx Oncology Secures Nasdaq Listing Amid Executive Reshuffle

September 18, 2025
Hain Celestial Stock

Hain Celestial Shares Plummet Following Catastrophic Quarterly Report

September 18, 2025
Xiaomi Stock

Xiaomi’s Strategic Product Offensive Targets Apple’s Market Dominance

September 18, 2025
FoxClass A Stock

Leadership Transition at Fox: Murdoch Consolidates Control Amid Strategic Shifts

September 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Can a New Board Appointment Reverse CONMED’s Fortunes? September 18, 2025
  • Alx Oncology Secures Nasdaq Listing Amid Executive Reshuffle September 18, 2025
  • Hain Celestial Shares Plummet Following Catastrophic Quarterly Report September 18, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com